The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience

P. Jain, H. Kantarjian, F. Ravandi, D. Thomas, S. O'Brien, T. Kadia, J. Burger, G. Borthakur, N. Daver, E. Jabbour, M. Konopleva, J. Cortes, N. Pemmaraju, M. A. Kelly, M. Cardenas-Turanzas, R. Garris, S. Faderl

Research output: Contribution to journalLetter

27 Scopus citations
Original languageEnglish (US)
Pages (from-to)973-975
Number of pages3
JournalLeukemia
Volume28
Issue number4
DOIs
StatePublished - Apr 2014
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Jain, P., Kantarjian, H., Ravandi, F., Thomas, D., O'Brien, S., Kadia, T., Burger, J., Borthakur, G., Daver, N., Jabbour, E., Konopleva, M., Cortes, J., Pemmaraju, N., Kelly, M. A., Cardenas-Turanzas, M., Garris, R., & Faderl, S. (2014). The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience. Leukemia, 28(4), 973-975. https://doi.org/10.1038/leu.2013.312